Lymphangioleiomyomatosis: a case-control study of perinatal and early life events

Whale C I; Johnson S R; Phillips K G; Newton S A; Lewis S A; Tattersfield A E
November 2003
Thorax;Nov2003, Vol. 58 Issue 11, p979
Academic Journal
BACKGROUND: Lymphangioleiomyomatosis (LAM), a rare disease affecting women, is caused by somatic mutations in the tuberous sclerosis complex genes. METHODS: A case-control questionnaire study was carried out examining parental and family history, prenatal events, and early life events to try to shed light on the aetiology of the condition. Forty five patients identified from a national LAM register completed a questionnaire and 31 were compared with 117 age and sex matched control subjects using conditional logistic regression. RESULTS: No differences were found in perinatal events, childhood infections, and parental or family history, except that patients were more likely to be an only child (odds ratio (OR) 4.3 (95% confidence interval (CI), 1.5 to 11.8)) and have a relative with uterine fibroids (OR 4.2 (1.4 to 13)). Patients with LAM had had fewer pregnancies and fewer children but no differences in miscarriage rates. A non-matched analysis using all 45 cases and 117 controls gave similar results. CONCLUSIONS: No features in the family history, perinatal events, or early life events were detected that were associated with having LAM. Being more likely to be an only child and having an increased family history of uterine fibroids may, if confirmed, indicate some differences in reproductive function within the families of affected individuals.


Related Articles

  • Lymphangioleiomyomatosis and Tuberous Sclerosis Complex. Chorianopoulos, Dimitrios; Stratakos, Grigoris // Lung;Jul/Aug2008, Vol. 186 Issue 4, p197 

    Lymphangioleiomyomatosis (LAM) is a rare multisystemic disease of women of child-bearing age and affects mainly the lungs, promoting cystic destruction of lung parenchyma or leading to abdominal tumor formation (e.g., angiomyolipomas, lymphangioleiomyomas). LAM can arise sporadically or in...

  • Exertional haemoptysis: LAM and TSC. Badawi, R.A.; Geddes, D.M. // Thorax;May2003, Vol. 58 Issue 5, p460 

    Considers the need of such a diagnosis in female patients presenting with solitary exertional haemoptysis. Fulfillment of the criteria for a diagnosis of lymphangioleiomyomatosis and tuberous sclerosis (TSC); Association of TSC with epilepsy, learning difficulties, behavioral problems and renal...

  • Molecular Pathology of Lymphangioleiomyomatosis and Other Perivascular Epithelioid Cell Tumors. Martignoni, Guido; Pea, Maurizio; Reghellin, Daniela; Gobbo, Stefano; Zamboni, Giuseppe; Chilosi, Marco; Bonetti, Franco // Archives of Pathology & Laboratory Medicine;Jan2010, Vol. 134 Issue 1, p33 

    Context.-Lymphangioleiomyomatosis (LAM) is a cystic lung disease that can be included in the wide group of proliferative lesions named PEComas (perivascular epithelioid cell tumors). These proliferative tumors are characterized by the coexpression of myogenic and melanogenesisrelated markers. In...

  • Poster presentations: 3. Molecular Genetics.  // Journal of Medical Genetics;Sep2002 Supplement, Vol. 39, pS78 

    Discusses the abstract of the research paper entitled 'Development of a diagnostic quantitative PCR strategy for the analysis of TSC2 gene rearrangements,' by Peter Davies and presented during the British Human Genetics Conference at the University of York in England in September 2002.

  • Ethanol/iodised oil.  // Reactions Weekly;8/29/2009, Issue 1267, p16 

    The article describes the case of a 22-year-old female patient with tuberous sclerosis complex (TSC) and pulmonary lymphangioleiomyomatosis (LAM) who acquired pulmonary oedema on two occasions following transcatheter embolisation with a 7:3 mixture of absolute alcohol and iodized oil. The woman...

  • Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors. Rakowski, S. K.; Winterkorn, E. B.; Paul, E.; Steele, D. J. R.; Halpern, E. F.; Thiele, E. A. // Kidney International;Nov2006, Vol. 70 Issue 10, p1777 

    Tuberous sclerosis complex is a genetic disorder characterized by hamartomatous lesions in multiple organs, frequently involving the kidney. We conducted a retrospective review of the clinical and radiographic records of 167 patients with tuberous sclerosis to determine the frequency of renal...

  • MicroRNA-21 is Induced by Rapamycin in a Model of Tuberous Sclerosis (TSC) and Lymphangioleiomyomatosis (LAM). Trindade, Anil J.; Medvetz, Douglas A.; Neuman, Nicole A.; Myachina, Faina; Yu, Jane; Priolo, Carmen; Henske, Elizabeth P. // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Lymphangioleiomyomatosis (LAM), a multisystem disease of women, is manifest by the proliferation of smooth muscle-like cells in the lung resulting in cystic lung destruction. Women with LAM can also develop renal angiomyolipomas. LAM is caused by mutations in the tuberous sclerosis complex genes...

  • lesson of the month (1) Tuberous sclerosis presenting with confusion and agitation. Konda, Shruthi // Clinical Medicine;Oct2011, Vol. 11 Issue 5, p502 

    This lesson describes a case of tuberous sclerosis presenting with confusion and agitation. The condition is briefly reviewed and learning points are emphasised for clinicians encountering similar presentations.

  • Esclerosis tuberosa. Padilla-Vázquez, Felipe; Mendizábal-Guerra, Rafael; Arcipreste, Arturo Ayala; Acosta-Garces, Rubén; Melo-Guzmán, Gustavo; Rosas-Mora, Ivonne // Archivos de Neurociencias;abr-jun2012, Vol. 17 Issue 2, p132 

    The first descriptions of tuberous sclerosis were reported in 1880 by Desire Maloire Bourneville, who determinates thereafter the descriptions of the cerebral patology and the neurologic signs. It was until the beginnings of the XX century that were aquisited more imagine and clinic information...


Read the Article


Sign out of this library

Other Topics